DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease (PAD)

Not Applicable

Conditions: Claudication

Interventions: Other: Exercise Training
Other: Normal routine

First Posted Date: 2010-11-01

Last Posted Date: 2013-02-22

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 75

Registration Number: NCT01231360

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Clinical Trial of a Silver Eluting Dressing System

Phase 4

Completed

Conditions: Vascular Disease
Surgery

Interventions: Other: Surgical dressing

First Posted Date: 2010-10-27

Last Posted Date: 2016-01-12

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 500

Registration Number: NCT01229358

Locations: 🇺🇸
Michael Debakey Veterans Affairs Medical Center, Houston, Texas, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Refining Information Technology Support for Genetics in Medicine

Conditions: Hearing Loss
Cancer
Hypertrophic Cardiomyopathy

Interventions: Device: GeneInsight Clinic (GIC)

First Posted Date: 2010-10-21

Last Posted Date: 2014-01-24

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 40

Registration Number: NCT01225978

Locations: 🇺🇸
Children's Hospital Boston's Ear, Nose, and Throat Clinic, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital Division of Pulmonary Oncology, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital's Hypertrophic Cardiomyopathy Clinic, Boston, Massachusetts, United States

and more 6 locations

Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran

Phase 3

Withdrawn

Conditions: Back Pain

Interventions: Drug: Savella

First Posted Date: 2010-10-15

Last Posted Date: 2017-01-12

Lead Sponsor: Brigham and Women's Hospital

Registration Number: NCT01221740

Locations: 🇺🇸
Brigham and Women's Hospital Pain Trials Center, Chestnut Hill, Massachusetts, United States

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis

Phase 2

Completed

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Other: Oxygen
Drug: inhaled carbon monoxide

First Posted Date: 2010-10-04

Last Posted Date: 2017-06-14

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 58

Registration Number: NCT01214187

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States

and more 5 locations

Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis

Phase 4

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Milnacipran
Drug: Placebo

First Posted Date: 2010-09-23

Last Posted Date: 2014-11-17

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 49

Registration Number: NCT01207453

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

A Risk Based Approach to Improving Chronic Kidney Disease Management

Phase 3

Completed

Conditions: Chronic Kidney Disease

Interventions: Other: Electronic Decision Support

First Posted Date: 2010-09-16

Last Posted Date: 2013-02-15

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 10000

Registration Number: NCT01203813

Locations: 🇺🇸
Harvard Vanguard Medical Associates, Newton, Massachusetts, United States

Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru

Completed

Conditions: Tuberculosis, Multidrug-Resistant

Interventions: Other: e-Chasqui

First Posted Date: 2010-09-15

Last Posted Date: 2017-10-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 1849

Registration Number: NCT01201941

Locations: 🇵🇪
Socios En Salud, Lima, Peru

Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study

Recruiting

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2010-08-09

Last Posted Date: 2024-08-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 2000

Registration Number: NCT01177618

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Vitamin D and Omega-3 Trial (VITAL)

Phase 3

Active, not recruiting

Conditions: Cancer
Cardiovascular Disease

Interventions: Dietary Supplement: Vitamin D3 placebo
Dietary Supplement: vitamin D3
Drug: omega-3 fatty acids (fish oil)
Dietary Supplement: Fish oil placebo

First Posted Date: 2010-07-26

Last Posted Date: 2024-08-09

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 25871

Registration Number: NCT01169259

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy